Pillstats
Rx only · Injection · Intravenous

Rocuronium Bromide

Rocuronium Bromide

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCM03AC09
RxCUI (US)32521
US makers11 labelers
Packages25
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.113$0.227$0.340$0.453Mar 2026Apr 2026Apr 2026
$0.394
Latest avg · Apr 22, 2026
+0%
Since Mar 18, 2026
11
Active US suppliers
32%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.8K5.7K8.5K11K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.9K
Rx · 2026 Q1
4.7K
Units dispensed
-71%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Meitheal Pharmaceuticals Inc.unknown4SUPPLYING
Lifestar Pharma LLCunknown4SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING
Baxter Healthcare Corporationunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Solco Healthcare US, LLCunknown2SUPPLYING
Gland Pharma Limitedunknown2SUPPLYING
Medical Purchasing Solutions, LLCunknown2SUPPLYING
Civica, Inc.unknown2SUPPLYING
Mylan Institutional LLCunknown2SUPPLYING
B. Braun Medical Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 15, 2023
    SHORTAGEDrug shortage: Rocuronium Bromide Injection (Sagent Pharmaceuticals)

    Rocuronium Bromide Injection — reported in shortage by Sagent Pharmaceuticals. Therapeutic category: Anesthesia.

  • Feb 15, 2023
    SHORTAGEDrug shortage: Rocuronium Bromide Injection (Hikma Pharmaceuticals USA, Inc.)

    Rocuronium Bromide Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Anesthesia.

  • Feb 15, 2023
    SHORTAGEDrug shortage: Rocuronium Bromide Injection (Mylan Institutional, a Viatris Company)

    Rocuronium Bromide Injection — reported in shortage by Mylan Institutional, a Viatris Company. Therapeutic category: Anesthesia.

  • Feb 15, 2023
    SHORTAGEDrug shortage: Rocuronium Bromide Injection (Meitheal Pharmaceuticals, Inc.)

    Rocuronium Bromide Injection — reported in shortage by Meitheal Pharmaceuticals, Inc.. Therapeutic category: Anesthesia.

  • Feb 15, 2023
    SHORTAGEDrug shortage: Rocuronium Bromide Injection (Baxter Healthcare)

    Rocuronium Bromide Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Anesthesia.